Literature DB >> 18834403

Tumor-vascular interactions and tumor dormancy.

George N Naumov1, Judah Folkman, Oddbjorn Straume, Lars A Akslen.   

Abstract

Tumor progression is dependent on a number of sequential steps, including initial tumor-vascular interactions and recruitment of blood vessels (i.e., the angiogenic switch), as well as tumor cells interacting with the surrounding microenvironment and its different components. Failure of a microscopic tumor to complete one or more of these early stages may lead to delayed clinical manifestation of the cancer and a state of stable non-progressing disease (i.e., tumor dormancy). In this review, some of the clinical and experimental evidence is summarized, suggesting that microscopic human cancers, either primary, recurrent or metastatic, can remain in an asymptomatic, non-detectable, and occult state for a long period of time. We also review current experimental human tumor dormancy models which closely recapitulate clinically observed delay in tumor progress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18834403     DOI: 10.1111/j.1600-0463.2008.01213.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  34 in total

Review 1.  Endothelial progenitor cells: current issues on characterization and challenging clinical applications.

Authors:  Thomas Resch; Andreas Pircher; Christian M Kähler; Johann Pratschke; Wolfgang Hilbe
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 2.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 3.  Photoacoustic imaging and characterization of the microvasculature.

Authors:  Song Hu; Lihong V Wang
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

4.  Tumor dormancy in bone.

Authors:  Vera Mayhew; Tolu Omokehinde; Rachelle W Johnson
Journal:  Cancer Rep (Hoboken)       Date:  2019-01-29

5.  Modeling boundary conditions for balanced proliferation in metastatic latency.

Authors:  Donald P Taylor; Jakob Z Wells; Andrej Savol; Chakra Chennubhotla; Alan Wells
Journal:  Clin Cancer Res       Date:  2013-01-17       Impact factor: 12.531

Review 6.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

Review 7.  Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.

Authors:  Louis de Mestier; Gilles Manceau; Cindy Neuzillet; Jean Baptiste Bachet; Jean Philippe Spano; Reza Kianmanesh; Jean Christophe Vaillant; Olivier Bouché; Laurent Hannoun; Mehdi Karoui
Journal:  World J Gastrointest Oncol       Date:  2014-06-15

8.  Modeling progression in radiation-induced lung adenocarcinomas.

Authors:  Hatim Fakir; Werner Hofmann; Rainer K Sachs
Journal:  Radiat Environ Biophys       Date:  2010-01-08       Impact factor: 1.925

9.  Molecular and clinical aspects of targeting the VEGF pathway in tumors.

Authors:  Grzegorz Korpanty; Laura A Sullivan; Elizabeth Smyth; Desmond N Carney; Rolf A Brekken
Journal:  J Oncol       Date:  2010-06-10       Impact factor: 4.375

10.  Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors.

Authors:  Michael S Rogers; Katherine Novak; David Zurakowski; Lorna M Cryan; Anna Blois; Eugene Lifshits; Trond H Bø; Anne M Oyan; Elise R Bender; Michael Lampa; Soo-Young Kang; Kamila Naxerova; Karl-Henning Kalland; Oddbjorn Straume; Lars A Akslen; Randolph S Watnick; Judah Folkman; George N Naumov
Journal:  Mol Cancer Res       Date:  2014-02-26       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.